期刊
MOLECULAR ASPECTS OF MEDICINE
卷 29, 期 5, 页码 290-308出版社
ELSEVIER
DOI: 10.1016/j.mam.2008.05.002
关键词
Matrixin; Tissue inhibitors of metalloproteinases; Cancer; Cardiovascular disease; Arthritis
资金
- Cancer Research UKl
- Medical Research Council
- European Union
- Wellcome Trust
- National Institutes of Health [AR40994]
- NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER
Matrix metalloproteinases (MMPs) are now acknowledged as key players in the regulation of both cell-cell and cell-extracellular matrix interactions. They are involved in modifying matrix structure, growth factor availability and the function of cell surface signalling systems, with consequent effects on cellular differentiation, proliferation and apoptosis. They play central roles in morphogenesis, wound healing, tissue repair and remodelling in response to injury and in the progression of diseases such as arthritis, cancer and cardiovascular disease. Because of their wide spectrum of activities and expression sites, the elucidation of their potential as drug targets in disease or as important features of the repair process will be dependent upon careful analysis of their role in different cellular locations and at different disease stages. Novel approaches to the specific regulation of individual MMPs in different contexts are also being developed. Crown Copyright (C) 2008 Published by Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据